Abstract
Oncolytic viral therapy is a promising biological therapy for the treatment of cancer. Recent advances in genetic engineering have facilitated the construction of custom-built oncolytic viruses that can be exquisitely targeted to tumors by exploiting each cancers unique biology and their efficacy can be further enhanced by “arming” them with additional therapeutic genes. Such an approach allows the virus to unload its “therapeutic cargo” at the tumor site, thereby enhancing its anti-neoplastic properties. While several clever strategies have been recently described using genes that can induce cellular apoptosis/suicide and/or facilitate tumor/virus imaging, viruses armed with genes that also affect the tumor microenvironment present an exciting and promising approach to therapy. In this review we discuss recently developed oncolytic viruses armed with genes encoding for angiostatic factors, inflammatory cytokines, or proteases that modulate the extracellular matrix to regulate tumor vascularization, anti-tumor immune responses and viral spread throughout the solid tumor.
Keywords: Oncolytic viruses, tumor microenvironment, angiogenesis, extracellular matrix, cytokines
Current Gene Therapy
Title: “Buy One Get One Free”: Armed Viruses for the Treatment of Cancer Cells and their Microenvironment
Volume: 9 Issue: 5
Author(s): Balveen Kaur, Timothy P. Cripe and E. Antonio Chiocca
Affiliation:
Keywords: Oncolytic viruses, tumor microenvironment, angiogenesis, extracellular matrix, cytokines
Abstract: Oncolytic viral therapy is a promising biological therapy for the treatment of cancer. Recent advances in genetic engineering have facilitated the construction of custom-built oncolytic viruses that can be exquisitely targeted to tumors by exploiting each cancers unique biology and their efficacy can be further enhanced by “arming” them with additional therapeutic genes. Such an approach allows the virus to unload its “therapeutic cargo” at the tumor site, thereby enhancing its anti-neoplastic properties. While several clever strategies have been recently described using genes that can induce cellular apoptosis/suicide and/or facilitate tumor/virus imaging, viruses armed with genes that also affect the tumor microenvironment present an exciting and promising approach to therapy. In this review we discuss recently developed oncolytic viruses armed with genes encoding for angiostatic factors, inflammatory cytokines, or proteases that modulate the extracellular matrix to regulate tumor vascularization, anti-tumor immune responses and viral spread throughout the solid tumor.
Export Options
About this article
Cite this article as:
Kaur Balveen, Cripe P. Timothy and Chiocca Antonio E., “Buy One Get One Free”: Armed Viruses for the Treatment of Cancer Cells and their Microenvironment, Current Gene Therapy 2009; 9 (5) . https://dx.doi.org/10.2174/156652309789753329
DOI https://dx.doi.org/10.2174/156652309789753329 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Shared Signaling Pathways Between Endocrine and Immune System Receptors: The Model of Gamma Chain
Current Signal Transduction Therapy Recent Advancement in Natural Hyaluronidase Inhibitors
Current Topics in Medicinal Chemistry Review of the Syntheses and Activities of Some Sulfur-Containing Drugs
Current Organic Synthesis Chronopharmacology and Antimicrobial Therapeutics
Current Clinical Pharmacology The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research
Current Drug Targets Immune-Neuroendocrine Dysregulation in Patients with Osteoarthritis: A Revision and a Pilot Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Pharmacogenomics of Methotrexate: Current Status and Future Outlook
Current Drug Metabolism Flaxseed and Endotoxic Shock
Current Pharmaceutical Design A Possible Approach for Stem Cell Gene Therapy of Fanconi Anemia
Current Gene Therapy Recent Advances in the Development of Novel Therapeutics Targeting Dendritic Cells
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Commentary (Brilliant Blue G: What a Little More Colour Can Be)
CNS & Neurological Disorders - Drug Targets Drotrecogin Alfa (Activated) in the Treatment of Severe Sepsis
Current Drug Safety Drugs Targeting the Canonical NF-κB Pathway to Treat Viral and Autoimmune Myocarditis
Current Pharmaceutical Design Current Advances in Novel SARS-CoV-2 Disease (COVID-19) Treatment and Intervention Strategies
Coronaviruses The Therapeutic Role of Taurine in Ischaemia-Reperfusion Injury
Current Pharmaceutical Design Human N-Acetyltransferases and Drug-Induced Hepatotoxicity
Current Drug Metabolism Update On Emerging Antivirals For The Management Of Herpes Simplex Virus Infections: A Patenting Perspective
Recent Patents on Anti-Infective Drug Discovery Interaction of ABC Multidrug Transporters with Anticancer Protein Kinase Inhibitors: Substrates and/or Inhibitors?
Current Cancer Drug Targets Towards Retinoid Therapy for Alzheimers Disease
Current Alzheimer Research Activation of p53 by Specific Agents in Potential Cancer Therapy
Current Medicinal Chemistry - Anti-Cancer Agents